That sure is good news, that NYC that has been hit hardest with cases and deaths, has 21% with antibodies and therefore safe to return to society(most likely) is fabulous news and upstate with only 3.6% also reflects lack of cases , both helpful in planning reopening. Sample size was 3000 and only people outside working in grocery stores or shopping tested and no testing of total quarantined people but it just started MONDAY and NY will ramp it up quickly to 20,000 for a better estimate. NY has done more testing than anywhere so their numbers carry more wait than NJ or elsewhere that has been hit hard by this virus.
I know there is a lot of hope for Remdesiver as a treatment option, but I mentioned last week about a monoclonal antibody drug called Leronlimab made by Cytodyn , a small Vancouver biotech company , that is having success in treatment of Covid and the FDA has approved 2 studies for use for mild/ moderate cases and for severe cases and results hopefully will be known by May 12. Leronlimab has already been in Phase 2 and Phase 3 trials for the treatment of AIDS and for some Breast cancer , so it’s Covid use was an afterthought as an experimental drug ( which needs approval from the FDA every time it is used) and the company is trying to get it used for compassionate use, which will not require individual person approval and can just be used by doctors on the frontline. The early success is apparently 2 fold but the biggest thing it is a viral inhibitor that prevents the bodies immune system from attacking that I presume is causing the deaths of people on ventilators . The side effects in the treated patients are minimal so far. Too soon to know, but this drug used in combination with others , might be the treatment protocol for Covid and even prevent people from getting to the moderate or severe stage